# Anita Deswal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anita-deswal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,297 |
| Field | Heart Failure Treatment and Management |
| h-index | 75 |
| i10-index | 184 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5028392913 |
| ORCID iD | 0000-0002-6147-9591 |
| Works | 554 |

## Researcher papers

Showing 12 of 19.

- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure/)
- [2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines](https://scholariq.org/papers/2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial-2/)
- [Diuretic Strategies in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/diuretic-strategies-in-patients-with-acute-decompensated-heart-failure/)
- [Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/effect-of-phosphodiesterase-5-inhibition-on-exercise-capacity-and-clinical/)
- [Cytokines and Cytokine Receptors in Advanced Heart Failure](https://scholariq.org/papers/cytokines-and-cytokine-receptors-in-advanced-heart-failure/)
- [2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary](https://scholariq.org/papers/2020-aha-acc-guideline-for-the-diagnosis-and-treatment-of-patients-with/)
- [Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome](https://scholariq.org/papers/ultrafiltration-in-decompensated-heart-failure-with-cardiorenal-syndrome/)
- [2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary](https://scholariq.org/papers/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive/)
- [Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association](https://scholariq.org/papers/current-diagnostic-and-treatment-strategies-for-specific-dilated/)
- [2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation](https://scholariq.org/papers/2023-acc-aha-accp-hrs-guideline-for-the-diagnosis-and-management-of-atrial/)
- [2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy](https://scholariq.org/papers/2020-aha-acc-guideline-for-the-diagnosis-and-treatment-of-patients-with-2/)
- [Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update](https://scholariq.org/papers/type-2-diabetes-mellitus-and-heart-failure-a-scientific-statement-from-the/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.